Investigation of the Influence of EPs® 7630, a Herbal Drug Preparation From Pelargonium Sidoides, on Replication of a Broad Panel of Respiratory Viruses.

Michaelis Martin, Doerr Hans Wilhelm, Cinatl Jr Jindrich
Phytomedicine, 2011

Abstract

The Pelargonium sidoides extract EPs® 7630 is an approved drug for the treatment of acute bronchitis in Germany. The postulated mechanisms underlying beneficial effects of EPs® 7630 in bronchitis patients include immunomodulatory and cytoprotective effects, inhibition of interaction between bacteria and host cells, and increase of cilliary beat frequency on respiratory cells. Here, we investigated the influence of EPs® 7630 on replication of a panel of respiratory viruses. Determination of virus-induced cytopathogenic effects and virus titres revealed that EPs® 7630 at concentrations up to 100 μg/ml interfered with replication of seasonal influenza A virus strains (H1N1, H3N2), respiratory syncytial virus, human coronavirus, parainfluenza virus, and coxsackie virus but did not affect replication of highly pathogenic avian influenza A virus (H5N1), adenovirus, or rhinovirus. Therefore, antiviral effects may contribute to the beneficial effects exerted by EPs® 7630 in acute bronchitis patients.

Copyright © 2010 Elsevier GmbH. All rights reserved.

PMID:21036571
PMCID (Free PMC Article):PMC7127141
DOI:10.1016/j.phymed.2010.09.008
Category:Immune

Articles similar to "Investigation of the Influence of EPs® 7630, a Herbal Drug Preparation From Pelargonium Sidoides, on Replication of a Broad Panel of Respiratory Viruses."

  • The significance of Pelargonium Sidoides for Immune: In Vitro Evaluation of Antibacterial and Immunomodulatory Activities of Pelargonium Reniforme, Pelargonium Sidoides and the Related Herbal Drug Preparation EPs® 7630. (The importance of Pelargonium species, most notably Pelargonium reniforme and Pelargonium sidoides, in traditional medicine in the Southern African region is well documented...)
  • The role of Pelargonium Sidoides in Immune: Pelargonium Sidoides Extract for Treating Acute Respiratory Tract Infections. ( Pelargonium sidoides (P... P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists. It may be effective in relieving symptoms in acute bronchitis in adults and children, and sinusitis in adults. The overall quality of the evidence was considered low for main outcomes in acute bronchitis in children and adults, and very low for acute sinusitis and the common cold. Reliable data on treatment for other ARIs were not identified.)
  • The significance of Pelargonium Sidoides for Immune: EPs® 7630 (Umckaloabo®), an Extract From Pelargonium Sidoides Roots, Exerts Anti-Influenza Virus Activity in Vitro and in Vivo. (A prodelphinidin-rich extract from Pelargonium sidoides DC, EPs® 7630 (Umckaloabo®), which is licensed to treat respiratory tract infections such as acute bronchitis, was investigated for its antiviral effects... P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists. It may be effective in relieving symptoms in acute bronchitis in adults and children, and sinusitis in adults. The overall quality of the evidence was considered low for main outcomes in acute bronchitis in children and adults, and very low for acute sinusitis and the common cold. Reliable data on treatment for other ARIs were not identified.)
  • The role of Pelargonium Sidoides in Immune: Anti-infective Activities of Pelargonium Sidoides (EPS® 7630): Effects of Induced NO Production on Leishmania Major in Infected Macrophages and Antiviral Effects as Assessed in a Fibroblast-Virus Protection Assay. (EPs® 7630 is an aqueous-ethanolic extract of the roots of Pelargonium sidoides, employed in the treatment of upper respiratory tract infections... P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists. It may be effective in relieving symptoms in acute bronchitis in adults and children, and sinusitis in adults. The overall quality of the evidence was considered low for main outcomes in acute bronchitis in children and adults, and very low for acute sinusitis and the common cold. Reliable data on treatment for other ARIs were not identified.)
  • The impact of Pelargonium Sidoides on Immune: Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium Sidoides (EPs ® 7630) in the Context of Health Promotion. (Pelargonium species contribute significantly to the health care of a large population in the Southern African region, as part of a long-standing medical system intimately linked to traditional healing practices... P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists. It may be effective in relieving symptoms in acute bronchitis in adults and children, and sinusitis in adults. The overall quality of the evidence was considered low for main outcomes in acute bronchitis in children and adults, and very low for acute sinusitis and the common cold. Reliable data on treatment for other ARIs were not identified.)
  • The significance of Pelargonium Sidoides for Immune: Use of Plant Extracts as an Efficient Alternative Therapy of Respiratory Tract Infections. (Medicinal plants are advantageously used in the treatment of respiratory tract diseases... P. sidoides may be effective in alleviating symptoms of acute rhinosinusitis and the common cold in adults, but doubt exists. It may be effective in relieving symptoms in acute bronchitis in adults and children, and sinusitis in adults. The overall quality of the evidence was considered low for main outcomes in acute bronchitis in children and adults, and very low for acute sinusitis and the common cold. Reliable data on treatment for other ARIs were not identified.)

Previous article

Pelargonium Sidoides Extract for Treating Acute Respiratory Tract Infections.

Next article

EPs® 7630 (Umckaloabo®), an Extract From Pelargonium Sidoides Roots, Exerts Anti-Influenza Virus Activity in Vitro and in Vivo.